Insights - OHE

European Union flag on the background of old locked doors

Insight
May 2023

New Drugs to Tackle Antimicrobial Resistance: Breaking the European Deadlock: Part 1 – Defining Objectives

On the dollar money are white medicine pills.

Insight
May 2023

The US Inflation Reduction Act: what do the experts think?

RWB Netherlands air balloon_landscape

Insight
May 2023

Around The World in HTAs: The Netherlands – 5 Routes for New Tech

Slovak discounting_andrik-langfield-0rTCXZM7Xfo-unsplash_landscape

Insight
May 2023

Setting the Right Discount Rate for HTA in the Slovak Republic

Optimise_AdobeStock_576507456_landscape

Insight
April 2023

How Restrictive are NICE ‘Optimised’ Decisions?

Italy_Balloon_AdobeStock_177931475_landscape

Insight
April 2023

Around The World in HTAs: Italy – What’s Next?

Informal Carer Burden Series: OHE on behalf of Roche

Insight
April 2023

Caring about Carers: Improving Consideration of the Burden of Informal Caring in HTA

Air balloon HTA v4

Insight
March 2023

Around The World in HTAs: Spain – Are We There Yet?

Eye-Disease Gene-Therapies blog

Insight
February 2023

Cost-effectiveness Analysis of Gene Therapies for Inherited Eye Disease: Are Current Discounting Approaches Too Short-sighted?

Fishing on the lake at sunset. Fishing background.

Insight
February 2023

Fishing for Innovative Drugs with the ODRS: Potential Benefits and Challenges

Cancer_WellcomeCollection_landscape

Insight
January 2023

Combination Therapies: A Step Forward to the Value Attribution Problem

G7Antibiotics_blog_featuredimage

Insight
December 2022

G7 Investments in New Antibiotics Would Pay Off – For Everyone

iStock-847519080_bw

Newsroom

The latest news and comment from OHE experts

Read Now

Subscribe To Our Newsletter

Our monthly Bulletin highlights our work alongside the latest from across health economics and health care.

Sign Up Now

Group 11119